Home > Focus Areas > KRAS Oncogene Connect > Post
A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer.
Yale Cancer Center Perspective Highlights New Advances for NSCLC
A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC). The goal of the study is to provide views on how basic science advances will impact clinical research areas to help influence how NSCLC will be managed over the coming decade.